XML 31 R21.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Based Compensation

Compensation costs that have been included in our condensed consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:

 

Stock-based compensation  2024   2023   2024   2023 
   Three Months Ended June 30,   Six Months Ended June 30, 
Stock-based compensation  2024   2023   2024   2023 
Cost of revenues  $49   $111   $94   $364 
Sales and marketing   17    35    31    132 
General and administrative   570    1,260    1,126    2,119 
Research and development   24    56    39    209 
Total stock-based compensation  $660   $1,462   $1,290   $2,824 
Schedule of Restricted Stock Unit Activity

A summary of our restricted stock unit activity for the six months ended June 30, 2024 is set forth below:

 

   Shares   Weighted Average Grant Date Fair Value 
Outstanding as of December 31, 2023   96,808   $25.21 
Granted   84,081    5.63 
Released   (110,570)   11.05 
Forfeited   (48)   46.50 
Outstanding as of June 30, 2024   70,271   $24.05 
Schedule of Stock Option Activity

A summary of our stock option activity under the 2018 Equity Incentive Plan (the “2018 Plan) and related information is as follows:

 

  

Number of

Shares

  

Weighted

Average

Exercise Price

  

Weighted

Average

Remaining

Contractual Term

(years)

  

Aggregate

Intrinsic

Value

 
Outstanding as of December 31, 2023   2,500   $56.89    4.2   $ 
Granted                  
Exercised                  
Forfeited                  
Outstanding as of June 30, 2024   2,500   $56.89    3.69   $ 
Exercisable as of June 30, 2024   2,500   $56.89    3.69   $ 

 

A summary of our option activity under our 2009 Equity Incentive Plan (the “2009 Plan”) and related information is as follows:

 

  

Number of

Shares

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual Term

(years)

  

Aggregate

Intrinsic

Value

 
Outstanding as of December 31, 2023   14,625   $39.67    2.9   $ 
Granted                  
Exercised                  
Forfeited   (8,802)   37.06           
Outstanding as of June 30, 2024   5,823   $43.62    2.97   $ 
Exercisable as of June 30, 2024   5,823   $43.62    2.97   $